PNC Financial Services Group
BCYC

PNC Financial Services Group’s Bicycle Therapeutics BCYC Stock Holding History

PNC Financial Services Group’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,138
Closed -$100K – 5173
2025
Q4 		$100K Buy
14,138
+1,058
+8% +$7.8K ﹤0.01% 2803
2025
Q3 		$101K Hold
13,080
– – ﹤0.01% 2798
2025
Q2 		$90.9K Hold
13,080
– – ﹤0.01% 2770
2025
Q1 		$111K Buy
13,080
+180
+1% +$2.12K ﹤0.01% 2597
2024
Q4 		$181K Hold
12,900
– – ﹤0.01% 2288
2024
Q3 		$292K Buy
12,900
+1,900
+17% +$43.8K ﹤0.01% 1926
2024
Q2 		$223K Buy
11,000
+3,300
+43% +$74.6K ﹤0.01% 2067
2024
Q1 		$192K Buy
7,700
+140
+2% +$2.97K ﹤0.01% 2206
2023
Q4 		$137K Buy
+7,560
New +$125K ﹤0.01% 2410

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PNC Financial Services Group's BCYC Position: Q1 2026 in Review

PNC Financial Services Group sold out of Bicycle Therapeutics (BCYC) in Q1 2026, closing a stake of 14,138 shares — an estimated $100K sold.

PNC Financial Services Group first reported a position in BCYC in Q4 2023 and held it in 9 quarters. The position peaked at $292K in Q3 2024. 98 funds tracked by Wall St. Rank hold BCYC as of Q1 2026.

  • PNC Financial Services Group reported no remaining Bicycle Therapeutics position as of Q1 2026 after selling out during the quarter.
  • PNC Financial Services Group sold 14,138 Bicycle Therapeutics shares in Q1 2026, an estimated $100K.
  • PNC Financial Services Group first reported a position in Bicycle Therapeutics in Q4 2023 and held it in 9 quarters.
  • PNC Financial Services Group's Bicycle Therapeutics position peaked at $292K in Q3 2024.
  • 98 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.